Page 182 - பல்கலைக்கழகம் ஆஃப் அலபாமா இல் பர்மிங்காம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Date Time Researchers Identify Potential Targets for Novel Treatments for Lung Cancer Lung cancer is the most common cause of cancer deaths, accounting for about a third of all tumor-related deaths. Adenocarcinomas, a non-small cell lung cancer (NSCLC), account for about 40 percent of cancer diagnoses, but few treatments are available for the disease. A team of investigators led by Elena Levantini, PhD, a research associate in Hematology-Oncology in the laboratory of Daniel Tenen MD, at Beth Israel Deaconess Medical Center (BIDMC), evaluated a novel agent, PTC596, capable of decreasing tumor growth in preclinical studies performed on a mouse model of mutant K-RAS lung cancer. The research – performed in collaboration with the Cancer Science Institute of Singapore at the National University of Singapore (CSI NUS) – were published today in the journal Communications Biology. The findings, which represent a comprehensive snapshot of the tumor’s components, will facilitate the d

United statesNational university of singaporeSingapore generalJunyan zhangHenry yangJohn clohessyMahmoud bassalJia liAzhar aliEva csizmadiaNicole pandellIndira krishnanRaphael buenoGiorgia maroniAllon kleinDanielg tenen